期刊文献+

新型冠状病毒肺炎恢复期肺纤维化的治疗思路与方法 被引量:12

Medication Thinking and Method of Pulmonary Fibrosis Treatment in Recovery Stage of COVID-19
暂未订购
导出
摘要 新型冠状病毒肺炎患者由于严重的肺损伤,后期可能遗留不同程度的肺间质改变,影像表现为纤维化样改变。核心病机是各种原因造成的肺中虚冷或肺热叶焦,其病理特点包括气虚、阴虚、毒、痰、瘀等方面。新型冠状病毒肺炎急性期经过治疗后,其转归主要有三:气阴两虚、挟湿挟瘀者,治宜益气养阴、宣肺化湿为要,可予沙参麦门冬汤合五叶芦根汤加减,气阴两虚甚者,用生脉饮、加减复脉汤加减;肺脾气虚、痰瘀滞络者,治疗多用六君子汤加减以健脾益气;气虚血瘀、肺络不畅者,可予麻杏石甘汤、葶苈大枣泻肺汤、宣白承气汤等,佐以活血化瘀药物,重者可加抵当汤。 Patients with corona virus disease 2019(COVID-19) may have varying degrees of lung interstitial changes in the later stage due to severe lung injury,and the images appear as fibrotic changes.The core pathogenesis is the deficiency Cold in the lung or the scorching of the lung Heat caused by various reasons.Its pathological characteristics include Qi deficiency,Yin deficiency,Toxin,Phlegm and Stasis.After the treatment of the COVID-19 in the acute phase,the main developing routes are the following three ones:with Qi and Yin deficiency as well as Dampness and Stasis,it is important to tonifying Qi and nourishing Yin to disperse Lung Qi and resolve Dampness,with mofified Shashen Maimendong Decoction combined with Wuye Lugen Decoction;for serious deficiency of Qi and Yin,modified Shengmai Yin and Fumai Decoction;for patients with deficiency of Lung and Spleen Qi with Phlegm and Stasis stagnating in collaterals,modified Liujunzi Decoction is used to improve Spleen Qi;for patients with Stasis and poor collaterals Maxing Shigan Decoction,Tingli Juzao Xiefei Decoction and Xuanbai Chengqi Decoction,etc.can be used accordingly,being supplemented with drugs for promoting blood circulation and removing blood stasis;for most serious cases,Didang Decoction can be used in treatment.
作者 丛晓东 曹庆 何沂 王冰 阮连国 樊茂蓉 苗青 任华 CONG Xiaodog;CAO Qing;HE Yi;WANG Bing;RUAN Lianguo;FAN Maorong;MIAO Qing;REN Hua(Xiyuan HospitalAffiliated to China Academy of Chinese Medical Sciences,Beijing China 100091;Beijing University of Chinese Medicine,Beijing China 100019;Wuhan Jinyintan Hospital,Wuhan Hubei China 400030)
出处 《中医学报》 CAS 2020年第8期1583-1586,共4页 Acta Chinese Medicine
基金 中央级公益性科研院所基本科研业务费专项资金资助项目(ZZ14-FY-004)。
关键词 新型冠状病毒肺炎 肺纤维化 气阴两虚、挟湿挟瘀证 肺脾气虚、痰瘀滞络证 气虚血瘀、肺络不畅证 COVID-19 Pulmonary Fibrosis Syndrome of Deficiency of Qi and Yin,Dampness and Stasis Syndrome Lung and Spleen Qi deficiency Syndrome,Phlegm and Stasis stagnating in collaterals Qi deficiency and Stasis Syndrome,Lung collateral stagnation Syndrome
  • 相关文献

参考文献15

二级参考文献119

共引文献1177

同被引文献255

引证文献12

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部